Correlation Between Passage Bio and NetScout Systems
Can any of the company-specific risk be diversified away by investing in both Passage Bio and NetScout Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and NetScout Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and NetScout Systems, you can compare the effects of market volatilities on Passage Bio and NetScout Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of NetScout Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and NetScout Systems.
Diversification Opportunities for Passage Bio and NetScout Systems
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Passage and NetScout is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and NetScout Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetScout Systems and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with NetScout Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetScout Systems has no effect on the direction of Passage Bio i.e., Passage Bio and NetScout Systems go up and down completely randomly.
Pair Corralation between Passage Bio and NetScout Systems
Given the investment horizon of 90 days Passage Bio is expected to generate 5.35 times more return on investment than NetScout Systems. However, Passage Bio is 5.35 times more volatile than NetScout Systems. It trades about 0.05 of its potential returns per unit of risk. NetScout Systems is currently generating about 0.11 per unit of risk. If you would invest 73.00 in Passage Bio on September 16, 2024 and sell it today you would earn a total of 3.00 from holding Passage Bio or generate 4.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Passage Bio vs. NetScout Systems
Performance |
Timeline |
Passage Bio |
NetScout Systems |
Passage Bio and NetScout Systems Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Passage Bio and NetScout Systems
The main advantage of trading using opposite Passage Bio and NetScout Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, NetScout Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetScout Systems will offset losses from the drop in NetScout Systems' long position.Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
NetScout Systems vs. Passage Bio | NetScout Systems vs. Black Diamond Therapeutics | NetScout Systems vs. Alector | NetScout Systems vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |